Reply: Estimation of lead-time and overdiagnosis in breast cancer screening
2009
Reply on Breast Cancer Screening Estimates
publication
Author Information
Author(s): Duffy S W, Lynge E, Jonsson H
Primary Institution: Cancer Research UK Centre for Epidemiology Mathematics and Statistics
Conclusion
The authors argue that their estimates of lead time and overdiagnosis in breast cancer screening are valid despite criticisms.
Supporting Evidence
- The authors state that their excess incidence of 39% was not claimed to estimate overdiagnosis.
- They argue that their estimate of 2.4 years lead time is consistent with other studies.
- The authors find the alternative approach to estimating lead time unconvincing due to methodological issues.
Takeaway
The authors believe their estimates about breast cancer screening are correct, even though others disagree.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website